# Vsee Health, Inc.: filings

VSEE · CIK 1864531 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vsee.md) · [Financials](/companies/vsee/financials.md) · [Filings](/companies/vsee/filings.md) · [Insiders](/companies/vsee/insiders.md)

## Reports and events: 134 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 92, 4 26, CORRESP 16, 3 15, 10-Q 14, 424B3 14, UPLOAD 14, D 8, S-4/A 8, SC 13G/A 7, DEF 14A 6, EFFECT 6, PRE 14A 6, S-1 6, SC 13G 6, 10-K 5, S-1/A 4, SCHEDULE 13G/A 4, NT 10-K 3, NT 10-Q 3, SC 13D 3, SCHEDULE 13G 3, DEFA14A 2, 10-K/A 1, 10-Q/A 1, 25-NSE 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DEFR14A 1, DRS 1, DRS/A 1, DRSLTR 1, POS EX 1, PRE 14C 1, PRER14A 1, S-4 1, S-8 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 21:29 ET | [S-1](/filings/0001185185-26-004518.md) | Registration statement | 0001185185-26-004518 |
| 2026-09-30 | 20:15 ET | [8-K](/filings/0001185185-26-004440.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-004440 |
| 2026-09-23 | 20:10 ET | [8-K](/filings/0001185185-26-004244.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-26-004244 |
| 2026-09-09 | 20:10 ET | [8-K](/filings/0001185185-26-003896.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-003896 |
| 2026-08-31 | 20:10 ET | [8-K](/filings/0001185185-26-003768.md) | 5.02 Departure or appointment of officers or directors | 0001185185-26-003768 |
| 2026-08-26 | 20:10 ET | [8-K](/filings/0001185185-26-003729.md) | 5.07 Shareholder vote results | 0001185185-26-003729 |
| 2026-08-14 | 20:12 ET | [10-Q](/filings/0001185185-26-003549.md) | Quarterly report, period 2026-06-30 | 0001185185-26-003549 |
| 2026-08-04 | 21:20 ET | [8-K](/filings/0001185185-26-003262.md) | 3.01 Delisting notice | 0001185185-26-003262 |
| 2026-07-31 | 20:31 ET | [8-K](/filings/0001185185-26-003211.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-003211 |
| 2026-07-24 | 20:30 ET | [8-K](/filings/0001185185-26-003124.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001185185-26-003124 |
| 2026-07-20 | 12:30 ET | [DEF 14A](/filings/0001185185-26-003024.md) | Proxy statement, period 2026-08-25 | 0001185185-26-003024 |
| 2026-07-10 | 20:31 ET | [8-K](/filings/0001185185-26-002887.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001185185-26-002887 |
| 2026-07-07 | 20:15 ET | [8-K](/filings/0001185185-26-002823.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002823 |
| 2026-06-26 | 20:33 ET | [8-K](/filings/0001185185-26-002686.md) | 2.04 Item not in the standard list | 0001185185-26-002686 |
| 2026-06-11 | 20:11 ET | [8-K](/filings/0001185185-26-002468.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002468 |
| 2026-06-11 | 20:10 ET | [8-K](/filings/0001185185-26-002467.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002467 |
| 2026-06-05 | 20:15 ET | [8-K](/filings/0001185185-26-002359.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001185185-26-002359 |
| 2026-05-15 | 19:21 ET | [10-Q](/filings/0001185185-26-001883.md) | Quarterly report, period 2026-03-31 | 0001185185-26-001883 |
| 2026-03-31 | 21:25 ET | [10-K](/filings/0001185185-26-001202.md) | Annual report, period 2025-12-31 | 0001185185-26-001202 |
| 2026-03-03 | 21:05 ET | [8-K](/filings/0001185185-26-000736.md) | 5.07 Shareholder vote results | 0001185185-26-000736 |
| 2026-02-19 | 22:15 ET | [8-K](/filings/0001185185-26-000625.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-26-000625 |
| 2026-02-05 | 15:15 ET | [DEF 14A](/filings/0001185185-26-000413.md) | Proxy statement, period 2026-03-02 | 0001185185-26-000413 |
| 2026-01-02 | 21:00 ET | [8-K](/filings/0001185185-26-000009.md) | 5.07 Shareholder vote results | 0001185185-26-000009 |
| 2025-12-29 | 21:33 ET | [S-1](/filings/0001185185-25-002184.md) | Registration statement | 0001185185-25-002184 |
| 2025-12-18 | 11:31 ET | [8-K](/filings/0001185185-25-002102.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-25-002102 |
| 2025-12-12 | 21:31 ET | [8-K](/filings/0001185185-25-002039.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-002039 |
| 2025-12-11 | 22:30 ET | [8-K](/filings/0001185185-25-002025.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-25-002025 |
| 2025-12-11 | 20:17 ET | [8-K/A](/filings/0001185185-25-002019.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-002019 |
| 2025-12-04 | 21:46 ET | [SCHEDULE 13D/A](/filings/0001213900-25-118335.md) | Ownership report, active investor, amended | 0001213900-25-118335 |
| 2025-11-28 | 21:18 ET | [8-K](/filings/0001185185-25-001884.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-001884 |
| 2025-11-26 | 21:40 ET | [8-K](/filings/0001185185-25-001870.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-25-001870 |
| 2025-11-24 | 21:10 ET | [DEF 14A](/filings/0001185185-25-001847.md) | Proxy statement, period 2025-12-15 | 0001185185-25-001847 |
| 2025-11-20 | 22:14 ET | [10-Q/A](/filings/0001185185-25-001818.md) | Quarterly report, amended, period 2025-06-30 | 0001185185-25-001818 |
| 2025-11-17 | 21:31 ET | [8-K](/filings/0001185185-25-001777.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-25-001777 |
| 2025-11-17 | 12:50 ET | [8-K](/filings/0001185185-25-001763.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-25-001763 |
| 2025-11-14 | 21:02 ET | [10-Q](/filings/0001185185-25-001744.md) | Quarterly report, period 2025-09-30 | 0001185185-25-001744 |
| 2025-10-29 | 11:01 ET | [8-K](/filings/0001185185-25-001563.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-25-001563 |
| 2025-10-28 | 20:16 ET | [8-K](/filings/0001185185-25-001551.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001185185-25-001551 |
| 2025-10-22 | 12:01 ET | [8-K](/filings/0001185185-25-001518.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-25-001518 |
| 2025-10-20 | 21:26 ET | [8-K](/filings/0001185185-25-001496.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-25-001496 |
| 2025-10-15 | 21:30 ET | [10-Q](/filings/0001185185-25-001450.md) | Quarterly report, period 2025-06-30 | 0001185185-25-001450 |
| 2025-10-15 | 21:22 ET | [10-Q](/filings/0001185185-25-001448.md) | Quarterly report, period 2025-03-31 | 0001185185-25-001448 |
| 2025-10-14 | 12:10 ET | [8-K](/filings/0001185185-25-001434.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001185185-25-001434 |
| 2025-10-10 | 01:34 ET | [8-K](/filings/0001185185-25-001417.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-25-001417 |
| 2025-09-29 | 00:19 ET | [8-K](/filings/0001185185-25-001289.md) | 3.01 Delisting notice | 0001185185-25-001289 |
| 2025-09-05 | 21:20 ET | [8-K](/filings/0001185185-25-001135.md) | 3.01 Delisting notice | 0001185185-25-001135 |
| 2025-08-29 | 10:17 ET | [10-K/A](/filings/0001558370-25-011815.md) | Annual report, amended, period 2024-12-31 | 0001558370-25-011815 |
| 2025-08-28 | 21:31 ET | [10-K](/filings/0001558370-25-011813.md) | Annual report, period 2024-12-31 | 0001558370-25-011813 |
| 2025-08-28 | 21:08 ET | [8-K](/filings/0001104659-25-084843.md) | 4.02 Non-reliance on financial statements | 0001104659-25-084843 |
| 2025-08-22 | 21:15 ET | [8-K](/filings/0001104659-25-081950.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-081950 |

Page 1 of 3. [Older](/companies/vsee/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.